Rankings
▼
Calendar
ELAN FY 2023 Earnings — Elanco Animal Health Incorporated Revenue & Financial Results | Market Cap Arena
ELAN
Elanco Animal Health Incorporated
$12B
FY 2023 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$4.4B
+0.1% YoY
Gross Profit
$1.9B
43.9% margin
Operating Income
$326M
7.4% margin
Net Income
-$1.2B
-27.9% margin
EPS (Diluted)
$-2.50
Cash Flow
Operating Cash Flow
$271M
Free Cash Flow
$117M
Stock-Based Comp.
$46M
Balance Sheet
Total Assets
$14.4B
Total Liabilities
$8.1B
Stockholders' Equity
$6.2B
Cash & Equivalents
$352M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$4.4B
$4.4B
+0.1%
Gross Profit
$1.9B
$2.0B
-1.6%
Operating Income
$326M
$384M
-15.1%
Net Income
-$1.2B
-$78M
-1478.2%
← Q4 2022
All Quarters
Q1 2023 →